Biomarker Summit 2013
|
Register
3 for the price of 2 with the coupon code
rcdvb! |
|
Dear Colleague,
GTC is proud to present the Biomarker Summit
2013, to be held on March 20-22, 2013 in San Francisco, California. Assembling
leading scientists, researchers, decision-makers and other players across the
industry spectrum, the Summit provides a unique opportunity to gain the latest
biomarker developments in three major therapeutic areas, formally organized in
the following tracks:
6th Oncology Biomarkers
2nd Neurological Biomarkers
2nd Inflammatory & Immunological Biomarkers
The summit will discuss a wide range of
issues such as biomarker identification and validation strategies, patient
stratification, enabling omics technologies, bioinformatics and systems biology
techniques, regulatory and reimbursement trends and the development of companion
diagnostics. These areas will be addressed in an intimate and highly
interactive environment with perspectives from industry, academia and the public
sector. Below is an agenda outline for the summit:
March 20th
Plenary Keynote Session
March 21st
Breakout: Oncology Biomarkers
Oncology Biomarker Discovery & Identification Strategies
Circulating / Body-Fluid Biomarkers
Diagnostic & Therapeutic Development for Cancer
Implementation
of Next-Generation Sequencing
Breakout: Neurological Biomarkers
Updates on Biomarkers in Alzheimer’s Disease
CSF / Blood-based Biomarkers Approaches
Biomarkers in Other Neurological Disorders
- Parkinson’s
- Huntington’s
- Schizophrenia
- Depression
- Autism
- Frototemporal Dementia
Breakout: Inflammatory / Immunological Biomarkers
Vascular & Metabolic Biomarkers
- Cardiovascular Disease
- Diabetes
- Atherosclerosis
- Myocardial Injury
- Stroke
Biomarkers in Allergy & Autoimmune Diseases
- Rheumatoid Arthritis
- SLE
- Asthma & COPD
- IBD
Development of Immunotherapy for Cancer
Mar 22nd
General Session
Regulatory & Reimbursement Updates in Biomarker Development
+ Panel Discussion
New Technologies & Novel Approaches to
Biomarker Development
Companion Diagnostics Development & Partnering Strategies
+ Panel Discussion
Call for Papers!
To be considered for an oral presentation, please submit an abstract
here by February 20, 2013. Selected presentations will be based on
quality of abstract and availability. Presentation slots fill up fast so please
submit your abstract ASAP.
Sponsorship and exhibiting opportunities are available in a range of levels,
which can be tailored to fit your needs. Please contact 626-256-6405 x102 or
spex@gtcbio.com
for more information.
Best Regards,
Organizing
Committee
See you in San Francisco!
|
| GOLD
SPONSOR |
|
 |
|
 |
|
 |
|
 |
|
|
SILVER SPONSOR |
|
 |
|
|
SUPPORTING SPONSOR |
|
 |
|
|
MEDIA
PARTNER |
|
 |
|
 |
|
|
 |
|
|
 |
|
|
|
 |
Attend ALL GTC Conferences for One Year
for only $3,995 ($1,990 for Acad/Govt).
Click
here to sign up! |
What Past Delegates Said About the Event:
"This was a very good conference that brought together scientist and managers
from industry and academia, presenting the progress, chances and challenges in
the biomarker arena. I liked in particular the size of the conference which was
very good for networking."
- Khusru Asadullah, Vice President, Head of Global Biomarker, Bayer Pharma
AG
“I found that participation at this conference was highly rewarding. Its size
was ideal for networking, and the program was a perfect mix of disease areas and
novel technologies.”
- Mark Broenstrup Sanofi-Aventis Deutschland GmbH, R&D Diabetes Division,
Biomarker&Diagnostics
“The smaller size of these meetings relative to the mega-conferences we often
attend is a welcome change! There were many opportunities to meet and talk with
other attendees one-on-one, and to my mind, that is one of the great benefits of
attending a meeting. The quality of the presentations was universally high."
- Mark Duncan, Professor of Medicine, School of Medicine, Endocrinology,
Metabolism, and Diabetes, University of Colorado
“A very informative 2 day conference on Biomarkers featuring a good selection of
speakers and topics – the best biomarker meeting I’ve attended in a while. The
size of the conference was great for networking. I made a lot of good contacts
there and learned a lot from the discussions I had with other attendees. The
location was great as well.”
- Paul Whittaker, PhD, Director, Respiratory Diseases Area, Novartis
Institutes for Biomedical Research
"The GTCbio conference put me in touch with a focused group of researchers from
all walks interested in advancing the same science. I've never connected with so
many potential research partners in such a short time."
- Timothy R. Church, Ph.D., Professor, Division of Environment Health
Science, University of Minnesota
|
|
|
